News | PrIMAVeRa

Newsroom

Check on PrIMAVeRa's latest news

Dec 10

PrIMAVeRa spotlighted in the latest AMR Accelerator Newsletter

December 2024 PrIMAVeRa is proud to be part of the IMI Antimicrobial Resistance (AMR) Accelerator, an Innovative Medicines Initiative...

Nov 22

Research priorities for tackling AMR released during World Antimicrobial Awareness Week 2024

A new manuscript focused on data needs for the development of vaccines and monoclonal antibodies (mAbs) to effectively address AMR was...

Nov 20

PrIMAVeRa 3rd annual meeting held in Seville on 07-08 November 2024

The third annual meeting of the PrIMAVeRa project took place on 07-08 November 2024 in Seville, Spain. Approximately 35 participants...

Nov 6

PrIMAVeRa meeting with Vaccines Europe on impact of vaccines in reduction of antimicrobial resistance

The PrIMAVeRa project, a public-private partnership supported by the European Federation of Pharmaceutical Industries and Associations...

Sep 24

Preserving European Antibiotics: The Need for Sustainable R&D Funding

Antibiotic resistance is a global public health threat. Modern health systems rely on antibiotics to prevent and treat infections, and...

Aug 13

PrIMAVeRa project publishes on contact network dynamics to prevent pathogen transmission in hospitals

Activities continue in the PrIMAVeRa project, with the latest result being the publication of a new manuscript titled “Using contact...

Jun 25

PrIMAVeRa project advances in combating AMR: key insights from year two progress review meeting

Divided into two rounds during June, Consortium partners presented year two progress to SAC.

May 15

PrIMAVeRa project partners present posters at ECCMID 2024

The team shared challenges & solutions for data-sharing & re-use, and expert consensus on priorities for vaccine/mAb R&D and implementation.

Mar 8

PrIMAVeRa participates in AMR Accelerator Cross-Project Meeting 2024

The Cross-Project Meeting gathered nearly 40 participants representing 9 IHI-funded projects from the AMR Accelerator, in Basel, Switzerland

Nov 24, 2023

PrIMAVeRa provides in-depth reports on current evidence base of burden of AMR in Europe

The PrIMAVeRa project proudly announces the simultaneous publication of four informative systematic reviews.

Nov 24, 2023

PrIMAVeRa 2nd annual meeting successfully held in hybrid format in Utrecht on 15-16 November 2023

The meeting enabled dynamic panel discussions covering the burden of AMR, and model development and data access.

Jun 19, 2023

PrIMAVeRa Project Appoints Scientific Advisory Committee

The PrIMAVeRa project announces the appointment of the Scientific Advisory Committee (SAC).

Nov 30, 2022

PrIMAVeRa 1st annual meeting successfully held in a hybrid event in Verona on 29-30 November 2022

PrIMAVeRa team gathered for the first project annual meeting with around 30 project partners joining in Verona (IT), and virtually.

Feb 3, 2022

PrIMAVeRa WP2 workshop, virtually held on 27-28 January 2022

The 2-day workshop included an overview of WP2, presentation and discussion of AMR case studies, the draft of AMR protocol, and more.

Dec 15, 2021

PrIMAVeRa kick-off meeting successfully marks the official project launch

The PrIMAVeRa consortium held its Kick-off Meeting on 25 November 2021 marking the official launch of this ambitious endeavor.

Nov 9, 2021

PrIMAVeRa, an ambitious project to demonstrate how vaccines can combat AMR

The IMI2 Joint Undertaking mobilises more than € 9 million to harnessing the power of big data and AI to steer the fight against AMR

Newsroom

Privacy Policy | Disclaimer | Contact us | Back to top